Form 4: Qualys Director Jeffrey P. Hank Executes Stock Option and Sells Shares Under 10b5-1 Plan

Qualys director Jeffrey P. Hank exercised stock options and sold shares on November 15, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On November 15, 2024, Qualys director Jeffrey P. Hank exercised a stock option to acquire 4,000 shares of common stock at a price of $40.68 per share.
• Following the exercise of the option, Mr. Hank sold a total of 4,000 shares in multiple transactions at weighted average prices ranging from $145.666 to $148.11 per share.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 16, 2024.
• After these transactions, Mr. Hank directly owns 12,666 shares of Qualys common stock.

Sentiment

Score: 5

Explanation: The document reflects routine insider trading activity under a pre-arranged plan, which is neither positive nor negative for the company's overall outlook.

Risks

• The sale of shares by a director could be perceived negatively by the market, although it was conducted under a pre-arranged trading plan.

Industry Context

This is a routine filing related to insider trading activity. It is common for executives and directors to use 10b5-1 plans to manage their stock sales and avoid accusations of insider trading.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a standard practice among corporate insiders to manage their stock transactions.
• The reported sale prices are within the typical range for market transactions of this type.
• Similar filings are common across all publicly traded companies, and the details are consistent with standard reporting requirements.

Stakeholder Impact

• The transactions have a minimal impact on stakeholders as they are part of a pre-arranged trading plan.

Key Dates

Keywords

Qualys, stock options, insider trading, Form 4, Rule 10b5-1, share sale, director, Jeffrey P. Hank